technetium tc 99m pentetate has been researched along with Idiopathic Pulmonary Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clotagatide, A; Goy, C; Leclerc, L; Montigaud, Y; Périnel-Ragey, S; Plantier, L; Pourchez, J; Prévôt, N | 1 |
| Anagnostopoulos, C; Black, CM; Denton, CP; Desai, SR; du Bois, RM; Goh, NS; Hansell, DM; Hoyles, RK; Sato, H; Wells, AU | 1 |
2 other study(ies) available for technetium tc 99m pentetate and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Development of an ex vivo preclinical respiratory model of idiopathic pulmonary fibrosis for aerosol regional studies.
Topics: Administration, Inhalation; Aerosols; Animals; Biomechanical Phenomena; Disease Models, Animal; Humans; Idiopathic Pulmonary Fibrosis; Lung; Respiration; Single Photon Emission Computed Tomography Computed Tomography; Swine; Technetium Tc 99m Pentetate | 2019 |
Increased epithelial permeability in pulmonary fibrosis in relation to disease progression.
Topics: Adult; Aged; Cohort Studies; Disease Progression; Epithelium; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Odds Ratio; Permeability; Prognosis; Proportional Hazards Models; Pulmonary Fibrosis; Radiopharmaceuticals; Technetium Tc 99m Pentetate; Treatment Outcome | 2011 |